Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.46 USD | +0.63% | +1.72% | -68.49% |
05-06 | Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib | MT |
05-06 | RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-68.49% | 14.66M | |
+0.10% | 91.42B | |
+2.76% | 41.08B | |
-9.06% | 34.26B | |
+55.39% | 25.27B | |
-16.61% | 15.27B | |
-9.14% | 12.81B | |
-12.11% | 11.6B | |
-43.61% | 11.42B | |
+7.87% | 9.16B |
- Stock Market
- Equities
- RDHL Stock
- News RedHill Biopharma Ltd.
- RedHill Biopharma : Cantor Fitzgerald Starts Redhill Biopharma at Overweight With $22 Price Target